How to Create Value for your Shareholders

Dr Robert Tansley talks at BioTrinity 2020

This session will look at the management practices of life sciences companies, in the context of creating value for shareholders. The expert panel will be addressing a range of considerations for how a company’s management team can employ smart business decisions to increase shareholder value, whilst also reflecting on the predicted impact that the current COVID-19 crisis will have on companies in the R&D sector both in the UK & US markets in the short, medium and long-terms.

Register here to access all the Panel discussions and more. 

BioTrinity 2020 is digitally delivered 28 April 2020 - 1 May 2020.